Halozyme Therapeutics (HALO) Tops Q2 EPS by 6c, Offers Guidance

Go back to Halozyme Therapeutics (HALO) Tops Q2 EPS by 6c, Offers Guidance
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 79.09 -1.28 (1.59%)
Previous Close $80.37    52 Week High $18.39 
Open $80.44    52 Week Low $6.96 
Day High $81.94    P/E N/A 
Day Low $78.95    EPS $-0.58 
Volume 745,055